🌏 Alzheimer’s risk cut in half by drug in landmark prevention trial | 👋 Can I ask you for something?

April 15 2026 Good News for Humankind 🌏 Your daily spark of possibility — one real milestone for change from around the world. Alzheimer’s risk cut in half by drug in landmark prevention trial A clinical trial from Washington University in St. Louis and published in The Lancet Neurology found that long-term high-dose treatment with the antibody drug gantenerumab reduced Alzheimer's risk by roughly 50% in people with dominantly inherited Alzheimer's disease — a rare genetic form caused by...